Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.510
+0.025 (1.68%)
At close: Mar 6, 2026, 4:00 PM EST
1.521
+0.011 (0.70%)
After-hours: Mar 6, 2026, 7:17 PM EST
Autolus Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Autolus Therapeutics stock have an average target of 8.50, with a low estimate of 5.00 and a high estimate of 10. The average target predicts an increase of 462.91% from the current stock price of 1.51.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Autolus Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 2 | 2 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 3 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +496.03% | Feb 17, 2026 |
| Needham | Needham | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +562.25% | Jan 12, 2026 |
| Needham | Needham | Strong Buy Maintains $10 → $11 | Strong Buy | Maintains | $10 → $11 | +628.48% | Dec 29, 2025 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +562.25% | Dec 12, 2025 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +562.25% | Nov 3, 2025 |
Financial Forecast
Revenue This Year
77.89M
from 10.12M
Increased by 669.62%
Revenue Next Year
140.02M
from 77.89M
Increased by 79.78%
EPS This Year
-1.01
from -0.86
EPS Next Year
-0.87
from -1.01
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 90.8M | 175.4M | ||||
| Avg | 77.9M | 140.0M | ||||
| Low | 70.1M | 119.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 797.5% | 125.1% | ||||
| Avg | 669.6% | 79.8% | ||||
| Low | 592.4% | 52.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.98 | -0.59 | ||||
| Avg | -1.01 | -0.87 | ||||
| Low | -1.04 | -1.09 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.